US equities |
MU $936.76 ▼-1.72% NVDA $223.52 ▼-2.19% AAPL $345.68 ▲+1.29% SPCX $153.84 ▼-1.73% META $742.96 ▼-2.56% TSLA $367.65 ▼-2.02% SNDK $1,426.33 ▼-3.78% AMD $581.50 ▼-3.97%
FinancialContent

Alaunos Therapeutics, Inc. - Common Stock (NQ:TCRT)

3.625 +0.595 (+19.64%)
Delayed Quote Updated: 11:16 AM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Alaunos Therapeutics, Inc. - Common Stock

News headline image
5 Biotech Stocks’ TCRT, IGC, PDSB, PFAI, Acquisition, Alzheimer’s, Cardio and Cancer Research Milestones
Via AB Newswire
Topics Artificial Intelligence
News headline image
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)
From PMGC Holdings Inc.
Via GlobeNewswire
Alaunos Therapeutics Inc.: 52-Week High Recently Eclipsed (TCRT)
Via Investor Brand Network
Alaunos Therapeutics Inc.: 52-Week High Recently Eclipsed (TCRT)
Via Investor Brand Network
Shares of Alaunos Therapeutics Inc. (TCRT) Rise Above Previous 52-Week High
Via Investor Brand Network